참고문헌
- Addla, S.K., Brown, M.D., Hart, C.A., Ramani, V.A., and Clarke, N.W. (2008). Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells. Am. J. Physiol. Renal Physiol. 295, F680-687. https://doi.org/10.1152/ajprenal.90286.2008
- Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355. https://doi.org/10.1038/nature02871
- Banerjee, P., Basu, A., Arbiser, J.L., and Pal, S. (2013). The natural product honokiol inhibits calcineurin inhibitor-induced and Rasmediated tumor promoting pathways. Cancer Lett. 338, 292-299. https://doi.org/10.1016/j.canlet.2013.05.036
- Cheng, L., Zhang, S., MacLennan, G.T., Lopez-Beltran, A., and Montironi, R. (2009). Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum. Pathol. 40, 10-29.
- Croce, C.M., and Calin, G.A. (2005). miRNAs, cancer, and stem cell division. Cell 122, 6-7. https://doi.org/10.1016/j.cell.2005.06.036
- Deng, X., Ma, L., Wu, M., Zhang, G., Jin, C., Guo, Y., and Liu, R. (2013). miR-124 radiosensitizes human glioma cells by targeting CDK4. J. Neurooncol. 114, 263-274. https://doi.org/10.1007/s11060-013-1179-2
- Fang, Y., Wei, J., Cao, J., Zhao, H., Liao, B., Qiu, S., Wang, D., Luo, J., and Chen, W. (2013). Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival. PLoS One 8, e62558. https://doi.org/10.1371/journal.pone.0062558
- Fried, L.E., and Arbiser, J.L. (2009). Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid. Redox Signal. 11, 1139-1148. https://doi.org/10.1089/ars.2009.2440
- Gregory, P.A., Bracken, C.P., Bert, A.G., and Goodall, G.J. (2008). MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7, 3112-3118. https://doi.org/10.4161/cc.7.20.6851
- Gupta, P.B., Onder, T.T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R.A., and Lander, E.S. (2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645-659. https://doi.org/10.1016/j.cell.2009.06.034
- Henrion, M., Frampton, M., Scelo, G., Purdue, M., Ye, Y., Broderick, P., Ritchie, A., Kaplan, R., Meade, A., McKay, J., et al. (2013). Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. Hum. Mol. Genet. 22, 825-831. https://doi.org/10.1093/hmg/dds489
- Huang, B., Huang, Y.J., Yao, Z.J., Chen, X., Guo, S.J., Mao, X.P., Wang, D.H., Chen, J.X., and Qiu, S.P. (2013). Cancer stem celllike side population cells in clear cell renal cell carcinoma cell line 769P. PLoS One 8, e68293. https://doi.org/10.1371/journal.pone.0068293
- Kong, D., Li, Y., Wang, Z., and Sarkar, F.H. (2011). Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins? Cancers 3, 716-729. https://doi.org/10.3390/cancers30100716
- Kumar, A., Kumar Singh, U., and Chaudhary, A. (2013). Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Future Med. Chem. 5, 809-829. https://doi.org/10.4155/fmc.13.32
- Lee, Y.J., Lee, Y.M., Lee, C.K., Jung, J.K., Han, S.B., and Hong, J.T. (2011). Therapeutic applications of compounds in the Magnolia family. Pharmacol. Ther. 130, 157-176. https://doi.org/10.1016/j.pharmthera.2011.01.010
- Liu, H., Zang, C., Emde, A., Planas-Silva, M.D., Rosche, M., Kuhnl, A., Schulz, C.O., Elstner, E., Possinger, K., and Eucker, J. (2008). Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur. J. Pharmacol. 591, 43-51. https://doi.org/10.1016/j.ejphar.2008.06.026
- Ma, L., Zhang, G., Miao, X.B., Deng, X.B., Wu, Y., Liu, Y., Jin, Z.R., Li, X.Q., Liu, Q.Z., Sun, D.X., et al. (2013). Cancer stem-like cell properties are regulated by EGFR/AKT/beta-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma. FEBS J. 280, 2027-2041. https://doi.org/10.1111/febs.12226
- Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715. https://doi.org/10.1016/j.cell.2008.03.027
- McLaughlin, J.K., Lipworth, L., and Tarone, R.E. (2006). Epidemiologic aspects of renal cell carcinoma. Semin. Oncol. 33, 527-533. https://doi.org/10.1053/j.seminoncol.2006.06.010
- Motzer, R.J., Mazumdar, M., Bacik, J., Berg, W., Amsterdam, A., and Ferrara, J. (1999). Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J. Clin. Oncol. 17, 2530-2540. https://doi.org/10.1200/JCO.1999.17.8.2530
- Moutasim, K.A., Nystrom, M.L., and Thomas, G.J. (2011). Cell migration and invasion assays. Methods Mol. Biol. 731, 333-343. https://doi.org/10.1007/978-1-61779-080-5_27
- Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., Nguyen, L.T., Hijiya, N., Uchida, T., Sato, F., et al. (2008). Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J. Pathol. 216, 418-427. https://doi.org/10.1002/path.2437
- Newman, D.J., Cragg, G.M., and Snader, K.M. (2003). Natural products as sources of new drugs over the period 1981-2002. J. Nat. Products 66, 1022-1037. https://doi.org/10.1021/np030096l
- Oates, J.E., Grey, B.R., Addla, S.K., Samuel, J.D., Hart, C.A., Ramani, V.A., Brown, M.D., and Clarke, N.W. (2009). Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers. Stem Cells Dev. 18, 1515-1522. https://doi.org/10.1089/scd.2008.0302
- Polyak, K., and Weinberg, R.A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273. https://doi.org/10.1038/nrc2620
- Ponnurangam, S., Mammen, J.M., Ramalingam, S., He, Z., Zhang, Y., Umar, S., Subramaniam, D., and Anant, S. (2012). Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol. Cancer Ther. 11, 963-972. https://doi.org/10.1158/1535-7163.MCT-11-0999
- Radisky, D.C., and LaBarge, M.A. (2008). Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2, 511-512. https://doi.org/10.1016/j.stem.2008.05.007
- Redova, M., Poprach, A., Besse, A., Iliev, R., Nekvindova, J., Lakomy, R., Radova, L., Svoboda, M., Dolezel, J., Vyzula, R., et al. (2013). MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol. 34, 481-491. https://doi.org/10.1007/s13277-012-0573-2
- Roy, S.S., Gonugunta, V.K., Bandyopadhyay, A., Rao, M.K., Goodall, G.J., Sun, L.Z., Tekmal, R.R., and Vadlamudi, R.K. (2013). Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene [Epub ahead of print].
- Singh, T., Prasad, R., and Katiyar, S.K. (2013). Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. Epigenetics 8, 54-65. https://doi.org/10.4161/epi.23078
- Taube, J.H., Malouf, G.G., Lu, E., Sphyris, N., Vijay, V., Ramachandran, P.P., Ueno, K.R., Gaur, S., Nicoloso, M.S., Rossi, S., et al. (2013). Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci. Rep. 3, 2687. https://doi.org/10.1038/srep02687
- Tian, W., Xu, D., and Deng, Y.C. (2012). Honokiol, a multifunctional tumor cell death inducer. Die Pharmazie 67, 811-816.
- Valster, A., Tran, N.L., Nakada, M., Berens, M.E., Chan, A.Y., and Symons, M. (2005). Cell migration and invasion assays. Methods 37, 208-215. https://doi.org/10.1016/j.ymeth.2005.08.001
- Wotschofsky, Z., Liep, J., Meyer, H.A., Jung, M., Wagner, I., Disch, A.C., Schaser, K.D., Melcher, I., Kilic, E., Busch, J., et al. (2012). Identification of metastamirs as metastasis-associated micro-RNAs in clear cell renal cell carcinomas. Int. J. Biol. Sci. 8, 1363-1374. https://doi.org/10.7150/ijbs.5106
- Xie, Y.K., Huo, S.F., Zhang, G., Zhang, F., Lian, Z.P., Tang, X.L., and Jin, C. (2012). CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma. J. Neurooncol. 110, 179-186. https://doi.org/10.1007/s11060-012-0961-x
- Xu, H., Mei, Q., Xiong, C., and Zhao, J. (2013). Tumor-suppressing effects of miR-141 in human osteosarcoma. Cell Biochem. Biophys. [Epub ahead of print].
- Yao, C.J., Lai, G.M., Yeh, C.T., Lai, M.T., Shih, P.H., Chao, W.J., Whang-Peng, J., Chuang, S.E., and Lai, T.Y. (2013). Honokiol eliminates human oral cancer stem-like cells accompanied with suppression of Wnt/ beta -catenin signaling and apoptosis induction. Evid. Based Complement. Alternat. Med. 2013, 146136.
- Yoshino, H., Enokida, H., Itesako, T., Tatarano, S., Kinoshita, T., Fuse, M., Kojima, S., Nakagawa, M., and Seki, N. (2013). Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma. J. Hum. Genet. 58, 508-516. https://doi.org/10.1038/jhg.2013.31
피인용 문헌
- Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells vol.7, 2016, https://doi.org/10.3389/fphar.2016.00423
- Honokiol targets mitochondria to halt cancer progression and metastasis vol.60, pp.6, 2016, https://doi.org/10.1002/mnfr.201501007
- Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells vol.6, pp.1, 2015, https://doi.org/10.1186/s13287-015-0177-z
- Targeting Cancer Stem Cells with Small Molecules vol.57, pp.3-4, 2017, https://doi.org/10.1002/ijch.201600109
- Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling vol.46, pp.6, 2015, https://doi.org/10.3892/ijo.2015.2950
- c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells vol.15, pp.17, 2016, https://doi.org/10.1080/15384101.2016.1201253
- MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression vol.482, pp.4, 2017, https://doi.org/10.1016/j.bbrc.2016.12.045
- miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma vol.374, pp.1, 2016, https://doi.org/10.1016/j.canlet.2016.01.032
- Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy vol.20, pp.2, 2016, https://doi.org/10.1007/s40291-016-0192-5
- Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds vol.17, pp.6, 2016, https://doi.org/10.3390/ijms17060893
- Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP vol.37, pp.12, 2016, https://doi.org/10.1038/aps.2016.81
- Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus 2015, https://doi.org/10.3109/10717544.2015.1020119
- Honokiol Metabolites Study in Rat Kidney Employing UHPLC-Q-TOF/MS and 13C Stable Isotope Labeling vol.78, pp.7-8, 2015, https://doi.org/10.1007/s10337-015-2859-1
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis vol.11, pp.6, 2015, https://doi.org/10.1007/s12015-015-9611-y
- MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy vol.7, pp.3, 2015, https://doi.org/10.3390/cancers7030855
- Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells vol.2016, 2016, https://doi.org/10.1155/2016/1490738
- MicroRNAs in the Pathogenesis of Renal Cell Carcinoma and Their Diagnostic and Prognostic Utility as Cancer Biomarkers vol.31, pp.1, 2016, https://doi.org/10.5301/jbm.5000174
- The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review vol.19, pp.1, 2018, https://doi.org/10.3390/ijms19010107
- The crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexity pp.00219541, 2019, https://doi.org/10.1002/jcp.28277
- E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells vol.7, pp.28, 2016, https://doi.org/10.18632/oncotarget.9715
- Protective Effect of Sinapine against Hydroxyl Radical-Induced Damage to Mesenchymal Stem Cells and Possible Mechanisms vol.64, pp.4, 2014, https://doi.org/10.1248/cpb.c15-00850
- SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension vol.8, pp.24, 2014, https://doi.org/10.18632/oncotarget.17165
- miR-211-5p Suppresses Metastatic Behavior by Targeting SNAI1 in Renal Cancer vol.15, pp.4, 2014, https://doi.org/10.1158/1541-7786.mcr-16-0288
- Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial–mesenchymal transition vol.11, pp.None, 2018, https://doi.org/10.2147/ott.s168317
- Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes vol.10, pp.None, 2014, https://doi.org/10.3389/fgene.2019.00320
- The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges vol.8, pp.10, 2014, https://doi.org/10.3390/cells8101118
- Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids vol.11, pp.12, 2014, https://doi.org/10.3390/cancers11121841
- Honokiol: A Review of Its Anticancer Potential and Mechanisms vol.12, pp.1, 2014, https://doi.org/10.3390/cancers12010048
- MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy vol.10, pp.7, 2014, https://doi.org/10.3390/biom10071040
- ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of t vol.21, pp.1, 2020, https://doi.org/10.1186/s12931-020-1281-x